Loading...
OCGN Ocugen
Loading...
News
Ocugen Inc. Stock Rises Monday, Outperforms Market
DJ Ocugen Inc. Stock Rises Monday, Outperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) advanced 1.86
7 penny stocks to buy that could be reddit investors’ next short squeeze
Reddit stocks and short-squeeze candidates have been the talk of Wall Street all year long. Let's look at seven penny stocks that could be next.
Ocugen Inc. Stock Falls Friday, Underperforms Market
DJ Ocugen Inc. Stock Falls Friday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) slid 1.05%
Ocugen To Participate In Fireside Chat At Cantor Global Healthcare Conference Sept. 28 at 8 a.m. EDT
Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, to
Ocugen, Inc. To Participate In Fireside Chat At Cantor Virtual Global Healthcare Conference Sept. 28
Ocugen, Inc. To Participate In Fireside Chat At Cantor Virtual Global Healthcare Conference Sept. 28
Ocugen, Inc. to Participate in Fireside Chat at the Cantor Virtual Global Healthcare Conference
MALVERN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness dis
Ocugen Inc. Stock Underperforms Wednesday When Compared To Competitors
DJ Ocugen Inc. Stock Underperforms Wednesday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc.
Ocugen Inc. Stock Outperforms Market On Strong Trading Day
DJ Ocugen Inc. Stock Outperforms Market On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) ralli
Bharat Biotech has Completed Phase 2 and 3 Clinical Trials of Covaxin for Use in Children 2 to 18 Years; Chairman Krishna Ella said Covaxin Production would Reach 55M Doses in October vs 35M in Septem
Live Mint https://www.livemint.com/news/india/bharat-biotech-completes-covaxin-phase-2-3-clinical-trials-for-children-11632213730051.html
Ocugen Inc. Stock Falls Monday, Underperforms Market
DJ Ocugen Inc. Stock Falls Monday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) shed 6.18%